◆◇學術研討會◆◇ A Workshop on the Development of a National Blood Product Program for Taiwan, R.O.C. 時間:五月十五日∼十六日 地點:生物化學所一樓講堂 主辦單位:生物化學研究所、國家衛生研究院 五月十五日 I. Purpose:The Need and the Impact 09:00∼09:05 Teh-Yung Liu:Introductory Remarks:Purpose of the Workshop 09:05∼09:25 Kuo-Sin Lin:The Need from the Medical and Public Health Point of View 09:25∼09:45 Weichen Tien:Rationale/Feasibility 09:45∼10:05 Cheng-Wen Wu:Impact II. Scope:The Procedures and Practices 10:05∼10:15 Teh-Yung Liu:An overview 10:15∼10:45 William N. Drohan:American Experience: Isolation of New Proteins and Recombinant Production 11:00∼11:30 Sujen Lin Tsai:Blood Establishment:Donor Suitability, Blood Collection, Storage, Computerization Manufacturers:Component Manufacturing, Product Testing, Quality Aassurance, Storage and Distribution, Lot Release, and Computerization. 11:30∼12:00 Donald Baker:US 14:00∼14:30 Shu-Len Liu:US 14:30∼15:00 Milton M. Mozen:US 15:00∼15:30 Yahiro Uemura:Japan 15:50∼16:20 Hans Hummel:Europe 16:20∼16:50 Khoo Kay Hooi:Physico-Chemical Characterization of Glycoproteins: Establishment of Chemical Identity 16:50∼17:20 Thierry Burnouf:Current trends and issues in modern plasma fractionation 17:20∼17:50 Mike Rodell:C. Clinical Trials:Once the "equivalency" has been established by A, B, limited clinical trials will be needed to assure safty and efficacy of the product 五月十六日 III. Production Concerns 09:00∼09:30 William Drohan:Safety Issues in Blood and Plasma:Virus Inactivation and Removal 09:30∼10:00 Mike Rodall:Regulatory concerns relating to the production and release of plasma proteins 10:00∼10:30 Mei-Ling Hsiao:(tentative) 10:30∼11:00 Chi-Byi Hong:Role NIPM may play in the National Blood Product Program IV. Executive Session:Round Table 11:00∼13:00 1.Evaluation of the two different fractionation systems. Which system is most suitable for Taiwan? 2.Organization of an action committee 3.Assignment of task for committee members 4.Date for next committee meeting